UNC13D LV vector expressing UNC13D cDNA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UNC13D LV vector expressing UNC13D cDNA, covering 2024-12-16 to 2024-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Gene Therapy of FHL Type 3 Caused by Mutations in the Human UNC13D Gene by Transplantation of a Single Dose of Autologous CD34+ Cells Transduced Ex Vivo with the UNC13D LV Vector Expressing the UNC13D CDNA [Phase 1, Phase 2]